MORI-BUILDING
24.1.2023 03:01:40 CET | Business Wire | Press release
Mori Building Co., Ltd., Japan’s leading urban landscape developer, announced today that the 49-story Toranomon Hills Station Tower will open this coming autumn. This project is being led by the Toranomon 1 & 2-chome District Urban Redevelopment Association, in which Mori Building is a leading participant. With the birth of Toranomon Hills Station Tower, which currently is being thoroughly integrated with Toranomon Hills Station, the entire Toranomon Hills area, which has been expanding and evolving at an unprecedented speed toward the realization of a new international hub and global business center, will be completed as a “city” boasting a scale and impact comparable to that of Roppongi Hills.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230123005232/en/
Completion image of Toranomon Hills (Note: please be sure to state the copyright “©The Boundary” when using this image.) (Graphic: Business Wire)
Toranomon Hills Station Tower is a multi-purpose 266-meter high tower with 49 floors above ground and 4 floors underground. By integrating the overall development with Toranomon Hills Station on the Tokyo Metro Hibiya Line, the tower will be complemented by a large and bustling station plaza and a pedestrian deck measuring 20 meters in width above Sakurada-dori Avenue (National Route 1), offering access to Toranomon Hills Mori Tower Oval Square. By strengthening and expanding the local multilevel transportation network on the ground, underground and the deck-level, the Station Tower will greatly enhance the Toranomon Hills as a transportation node and will enliven the entire area by significantly improving pedestrian flows.
The Station Tower will offer world-class office, as well as retail facilities integrated with the station plaza and a hotel making its debut in Tokyo. The tower‘s top-most level will be home to TOKYO NODE, an interactive communication facility consisting of halls, galleries, pool, restaurants, and other facilities fully capable of creating new values, ideas and business transcending domains, aimed at sharing creativity with the world.
The Toranomon Hills will be expanded to 7.5ha and total floor space of 800,000m2 with the opening of Toranomon Hills Station Tower in autumn, 2023. The area is steadily evolving as a mixed‐use complex integrated with urban infrastructures such as road and subway, with an impact comparable to that of Mori Building's epoch-making Roppongi Hills.
Open and Lively “Station Atrium” Created through Integrated Development of Station and Neighborhood
The Station Atrium (2,000m2) is a three-story atrium-style vaulted space combining coordinated and complementary urban and transportation functions.
The Station Atrium’s direct connections between the station plaza and nearby facilities for events and shopping keep the space bustling with a steady flow of people from morning till night.
20m-wide Large-scale Pedestrian T-Deck above Arterial Road
The 20m-wide large-scale pedestrian T-deck above Sakurada-dori Avenue (National Route 1) and connected to Toranomon Hills Mori Tower’s Oval Square. The elevated walkway, which passes through the Station Tower, is the main route for east-west pedestrian traffic, crossing districts and arterial road. It realizes safe urban spaces by separating pedestrians and vehicles in the area, and will function as a square linking people in Toranomon Hillls.
Interactive Communication Facility Connecting Tokyo with the World: TOKYO NODE
Toranomon Hills Station Tower’s top floors (45th to 49th floors, partly 8th) will be a home to TOKYO NODE, a 10,000m2 interactive communication facility.
Main hall and three galleries can be used individually or integrated as one contiguous venue. On the rooftop, sky garden, pool, and two restaurants curated by world-class chefs will open, including a grill restaurant supervised by Kei Kobayashi, the first Asian chef to earn three Michelin stars in Paris. The laboratory on the 8th floor, will further enhance the facility’s capacity as a highly functional and distinctive space for communication and knowledge-sharing, wholly unlike traditional conference and banquet facilities.
Furthermore, TOKYO NODE will serve as an information dissemination platform of for the entire Toranomon Hills area, allowing Toranomon Hills to evolve into a “communication hub” that attracts highly experienced and influential people from throughout the world for business creation and innovation to share globally.
New Office Space for Connecting People
Responding to Diverse Needs and New Workstyles
Office area located on 9th, 10th, 15-44th floors (total 32 floors), offers a total rental area measuring some 107,000 m2 and standard floors of about 3,400m2, including column-free plans with depths from core to window surface of about 18.5m, accommodate diverse workstyles and other needs of global companies.
In addition, eight "magnet zones" are equipped with atrium spaces and staircases, connecting the upper and lower floors to promote communication and collaboration among workers, and create more dynamic and creative workplaces.
Retail Facilities Support Global Players’ Work and Lives
A retail space measuring about 14,400m2 will occupy nine floors (B2-7th) with some 80 stores that support the work and lives of global players including office workers and residents.
The T‐Market (27 shops, approx. 3,000m2) will be full of life from morning till night (7am to 11pm) with restaurants, delis and stores. The restaurants will offer high-quality but reasonably priced menus, many curated by highly acclaimed chefs and pâtissiers, including some with Michelin or Bib Gourmand credentials.
Hotel Toranomon Hills: Tokyo's First Unbound Collection by Hyatt
The 1st floor and 11th to 14th floors will be home to the Hotel Toranomon Hills with 205 guest rooms including standard rooms measuring about 27m2 to 34m2. The hotel brand is “The Unbound Collection by Hyatt,” which will be making its debut in Tokyo as a part of “Independent Collection.”
It will serve as an “urban living room of Toranomon” welcoming a variety of guests with its restaurant, cafe and lounges open to the city.
All food and beverage experiences in the hotel‘s café and restaurant will be supervised by Sergio Herman,. Herman is a native of the Netherlands and longtime Michelin-starred chef and this will be his first foray into Japan.
World-leading Architects, Designers and Artists
- Design: Shohei Shigematsu (OMA)
The Design of Toranomon Hills Station Tower is OMA’s first large-scale architectural project in Tokyo.
Its design is based on ”THE ACTIVITY BAND” concept, or urban axis running from Shintora-dori Avenue to the Akasaka/Toranomon area, creating a symbolic place for people to gather and interact along the axis.
- Hotel Design (interior): Space Copenhagen
The hotel interior design is by Space Copenhagen, a Denmark Interior design firm, which will be their first interior design in Japan.
Multiple Global Environmental Certifications Received
Toranomon Hills area received preliminary Platinum certification, the highest rank in the LEED program’s ND category.
Station Tower’s offices and retail facilities have received preliminary Platinum certification in the BD+C:CS category and WELL preliminary certification and are expected to earn top Platinum certification once completed. It is Japan’s second largest precertified property, following the Azabudai Hills.
In addition, Station Tower will be 100% powered by RE100-compliant renewable energy from the time of its completion.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230123005232/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Samsung Bioepis Announces Positive Preliminary Phase 1 and Phase 3 Data for SB27, a Proposed Biosimilar to Keytruda (Pembrolizumab)29.6.2026 09:19:00 CEST | Press release
Phase 1 study demonstrated pharmacokinetic (PK) equivalence between SB27 and Keytruda; Phase 3 study demonstrated equivalent objective response rate (ORR) at Week 24Phase 1 and Phase 3 studies expected to be completed within 2026 Samsung Bioepis Co., Ltd. announced today that the Phase 1 and Phase 3 studies on SB27, a proposed biosimilar to Keytruda1 (pembrolizumab), have met their primary endpoints. “We are excited to announce preliminary results from the Phase 1 and Phase 3 studies for SB27, our pembrolizumab biosimilar candidate. These topline positive results reinforce our scientific expertise and leadership in biosimilar development,” said Donghoon Shin, Executive Vice President and Head of Clinical Sciences Division at Samsung Bioepis. “We are on track to complete both Phase 1 and Phase 3 studies within this year. Leveraging our robust quality management system, we remain committed to advancing our biosimilar portfolio to broaden access to life-saving biologic medicines for patie
IQM Named a Major Player in the IDC MarketScape: Worldwide Quantum Computing 2026 Vendor Assessment29.6.2026 09:00:00 CEST | Press release
IQM today announced it has been named a Major Player in the IDC MarketScape: Worldwide Quantum Computing 2026 Vendor Assessment. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260629748732/en/ IQM named a major player in the IDC MarketScape IQM believes this recognition comes as institutions worldwide move quantum computing out of shared cloud access and into infrastructure they own and operate themselves. IQM calls this Production Quantum: full-stack, open-architecture superconducting systems deployed on premises, inside customers' own data centers and HPC environments, where organizations own the hardware, build internal expertise, and run quantum processors alongside their existing classical infrastructure. According to the IDC MarketScape, "For institutions building long-term quantum programs, this means the workflows and intellectual property developed on IQM hardware remain portable." The report further advises: "Consi
Zambon Announces Positive CHMP Opinion for Hopledo® (IPX203) for Adults with Parkinson’s Disease and Moderate to Severe Motor Fluctuations29.6.2026 09:00:00 CEST | Press release
Positive CHMP opinion is based on data from the Phase 3 RISE-PD trial, which demonstrated significantly more “Good ON” time with fewer daily doses compared with immediate-release levodopa/carbidopa More than one million people are living with Parkinson’s disease in the European Union, and over 80% experience motor fluctuations during the course of their disease, highlighting the need for additional treatment options Hopledo® contains a unique formulation combining immediate-release granules and extended-release pellets, providing both a rapid onset of action and a longer duration of effect, sustaining the levodopa therapeutic effect for a longer period of time If approved, Zambon expects to make Hopledo® progressively available to patients with Parkinson’s disease across Europe starting October 2026 Zambon today announced that the Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the granting of a marketing authorization by the European M
Enhertu® Approved in the EU as First Tumor Agnostic HER2 Directed Therapy and Antibody Drug Conjugate for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors29.6.2026 08:30:00 CEST | Press release
Approval based on three phase 2 trials of Daiichi Sankyo and AstraZeneca’s Enhertu that demonstrated clinically meaningful responses across a broad range of tumors Enhertu now approved for six indications in the EU Enhertu® (trastuzumab deruxtecan) has been approved in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinion of the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on results from subgroups of patients with HER2 positive (IHC 3+) tumors across thr
Beerenberg Prevails in Patent Case Against Aspen Aerogels29.6.2026 07:00:00 CEST | Press release
The ruling confirms that Beerenberg did not infringe Aspen Aerogels’ patents. The Korean Patent Court has invalidated three of Aspen Aerogels’ patents related to improved hydrophobic aerogel material. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260628192007/en/ Beerenberg delivers high-end insulation solutions built for performance, reliability, and long-term value. (Photo: Beerenberg) The ruling confirms the conclusion of the Intellectual Property Trial and Appeal Board (IPTAB) that the patents did not meet the necessary requirements for patentability. Beerenberg, which specializes in high-end insulation products, welcomes the court’s decision. “We are pleased that the case has now been concluded and that any uncertainty regarding the infringement claims has been removed,” says CEO Arild Apelthun. About Beerenberg Beerenberg has delivered cost-efficient solutions to a wide range of industrial enterprises for 49 years. Th
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
